Multiplex Molecular in vitro Diagnostics

IntelliPlex™  SARS-CoV-2

The IntelliPlex™ SARS-CoV-2 detection platform provides an automated solution to address the urgent need for the high-volume testing during the Coronavirus disease 2019 (COVID-19) pandemic.

The IntelliPlex™ SARS-CoV-2 kit is a molecular in vitro diagnostic test that aids in the detection and diagnosis COVID-19 and is based on widely used nucleic acid amplification technology.

The IntelliPlex™ SARS-CoV-2 Detection Kit detects the presence of N, RdRp, and E genes of SARS-CoV-2 in RNA extracted from respiratory specimen.

Features include:
• Simultaneously detect 3 genes (E, N, and RdRp) in SARS-CoV-2 to minimize the probability of false negative test results due to the fast-evolving pace of this virus
• Process up to 564 samples in 9 hours. (96 rxns/kit)
• High sensitivity (140 copies/mL)


2-3 Week Installation
FDA EUA, CE-IVD 

EUA USER MANUAL
FACT SHEET FOR HEALTHCARE PROVIDERS
FACT SHEET FOR PATIENTS
SAFETY DATA SHEET
The PLEXBIO™ IntelliPlex™ SARS-CoV-2 Detection Platform

Request an Installation


Your Webinar Request Has Been Sent!

Your message has been sent successfully, We will respond within 24 hours. You may also contact us directly at [email protected]

3729 Main Street
College Park, GA, 30337

Ailm Medical LLC DBA NewNorm Platform
"Women Owned*
Website evolving in Real Time. Please excuse the construction.